Professor Andrew Wilks is a serial entrepreneur with 20 years commercial experience, following a successful academic career at the Ludwig Institute for Cancer Research. Andrew has discovered and named many novel protein kinases, including the JAK family of kinases, and went on to found Cytopia in 1997. Since then, Andrew has founded or co-founded ten drug discovery companies. In particular, he is co-founder of SYNthesis med chem, a global contract chemistry group with laboratories in China and more than 250 scientists world-wide.
September 8, 2022
CS Pharmaceuticals Ltd (“CSP” or “the Company”), a specialty pharmaceutical company focussed on the in-license of China rights of innovative products and the development and commercialisation of them…